Moderna has shared some of the phase 1/2 data that persuaded it to expand and prioritize development of a cancer candidate, reporting responses in melanoma patients failed by checkpoint inhibitors.

Gene-specific outcomes in patients with Lynch syndrome treated by immune checkpoint blockade for advanced cancer. Menopausal hormone therapy after a diagnosis of breast cancer in women with a BRCA ...

Autologous tumor-infiltrating lymphocytes (HS-IT101) with low-dose lymphodepletion and IL-2 infusion for the treatment of advanced solid tumors: A phase I clinical trial. This is an ASCO Meeting ...

SIGNA™ Sprint, a new wide bore 1.5T MRI scanner, is designed to provide power previously unattainable at 1.5T, for clarity in cardiology and oncology imaging Advanced high-performance gradient ...

Edgewise Therapeutics, Inc., (NASDAQ:EWTX) on Wednesday reported topline data of EDG-7500 from the Phase 2 CIRRUS-HCM four-week trial in participants with obstructive or nonobstructive Hypertrophic ...

Diffusion-weighted magnetic resonance imaging is essential for diagnosing ischemic stroke and identifying targets for emergency revascularization. Apparent diffusion coefficient (ADC) maps derived ...

NEUFELD, Austria, Feb. 25, 2025 /PRNewswire/ -- Sanochemia Pharmazeutika today announced positive headline results of the pivotal phase III study PROSTAPROGRESS on Ferumoxtran (EudraCT 2018-004310-18) ...